Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients
about
HIV Drug Resistance: Problems and PerspectivesBioinformatic analysis of HIV-1 entry and pathogenesis.Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapyParameters Influencing Baseline HIV-1 Genotypic Tropism Testing Related to Clinical Outcome in Patients on MaravirocChallenges and opportunities in estimating viral genetic diversity from next-generation sequencing dataRoutine use of microbial whole genome sequencing in diagnostic and public health microbiologyReconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence DataReliable genotypic tropism tests for the major HIV-1 subtypesCoverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies.Improving HIV coreceptor usage prediction in the clinic using hints from next-generation sequencing data.Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.A genotypic HIV-1 proviral DNA coreceptor tropism assay: characterization in viremic subjects.Limited evolution of inferred HIV-1 tropism while viremia is undetectable during standard HAART therapy"Deep" sequencing accuracy and reproducibility using Roche/454 technology for inferring co-receptor usage in HIV-1.Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis.A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1.Geno2pheno[454]: a Web server for the prediction of HIV-1 coreceptor usage from next-generation sequencing data.HIV-1 antiretroviral resistance: scientific principles and clinical applicationsRetroviral vectors for analysis of viral mutagenesis and recombination.A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patientsTargeted deep sequencing of HIV-1 using the IonTorrentPGM platformUse of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors.Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.Chemokine co-receptor usage in HIV-1-infected treatment-naïve voluntary counselling and testing clients in Southern Taiwan.Applications of next-generation sequencing technologies to diagnostic virology.HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to MaravirocIn-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection.Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods.Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.Evolution of coreceptor utilization to escape CCR5 antagonist therapy.Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing.Development of a novel codon-specific polymerase chain reaction for the detection of CXCR4-utilizing HIV type 1 subtype B.Clinical implications of HIV-1 minority variantsSensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection.Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients
P2860
Q26864534-CE0DD066-BDBF-48D1-8AE2-F82C502AA35DQ27693321-1761CF15-162E-4073-87FC-C4933D3546E0Q28541754-71111DE1-B8EA-4188-947C-2E9B45864C94Q28547216-C254745E-7C68-4034-99C0-1E5293507E5EQ28727944-EC477784-23CE-4C01-83A1-11EA8FDECE09Q28728617-3929B6C2-3C82-4202-8B3E-C69F4160D707Q29394572-FFBC4529-267D-4037-BD5F-97C075FE4DCDQ30372085-2A963CEC-F1A5-49EC-A325-F171D40E4473Q30425594-FFCAD400-9ABC-4F15-BCAE-69CDFBC65266Q30564042-C76A529B-8F7A-4C46-84CD-603B4774CB6AQ33622927-B93D1982-842A-410F-AFAC-F47FF843D755Q33712327-C2CD3439-08F8-4F93-9943-E3EF11ECC815Q33721466-2BA26D12-47BD-4D9A-805C-D59C45B391FEQ33800017-FD500C00-FCFB-4F4D-B774-DA0334666E16Q33899080-A83118B5-3100-4BDC-81CA-1883548F0A6DQ34062608-BA2B9065-9B45-4BFA-8B60-F8443759DB2CQ34144135-848D0660-255E-4A47-9C07-474E89C5575CQ34280466-91F06864-C6F8-41CD-BB13-4395DF65CC55Q34303615-D99169D8-8AAE-4D7A-8C63-279088B64AABQ34431102-79FAA85D-E6BD-46E0-BEA9-9FBF7C00AC75Q34451254-B66DF54B-F8EE-45BE-B8A6-74ADF74637B8Q34482589-FC96AF3C-FC1F-4469-B695-D7F4F8B2DBD8Q34558508-9D896F5C-BFB5-4F5F-8C25-4D03CA4A3845Q35270923-E2BE84C5-BC08-4293-8088-B84B54B753FBQ35330357-7CCF8FDF-AE05-4AC2-9BAF-DA05A88096E1Q35573197-AB00C4C1-EC29-4F24-A07B-CF433441F09EQ35600172-746A0466-414D-413C-AEBC-FF27C460873FQ35662019-13306923-9901-452F-829C-7C7B7165B4E2Q35790802-1E89EF1D-5E1B-43CE-81A1-7710F68DBA5BQ35806266-31DB1267-F164-460C-B88B-7829A3EF44C9Q35953203-0CD401C6-B99E-4379-874D-D7362230687AQ36003168-02433E59-2697-4443-863E-117991113D34Q36255602-D9490140-7FFE-4526-BDCF-269A412E8483Q36795929-85C19539-0F2E-4C3E-B98B-B8F18728159EQ36811249-1A510FBA-01A0-4BCF-BB92-461F03DB247EQ36826759-ABD11A59-D98E-48B0-9014-E1F70E94340BQ36933330-EF5A67CA-DBC6-4853-AF06-6AB072586920Q36936363-D13D91CE-0C12-4A55-896F-1CD8703E9032Q37174389-39D0863E-6384-4030-9ACB-12F1C8351ED4Q37288573-36F7E0B4-851C-4F22-89E9-4EDA85FF73E9
P2860
Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Deep sequencing to infer HIV-1 ...... treatment-experienced patients
@en
type
label
Deep sequencing to infer HIV-1 ...... treatment-experienced patients
@en
prefLabel
Deep sequencing to infer HIV-1 ...... treatment-experienced patients
@en
P2093
P2860
P356
P1476
Deep sequencing to infer HIV-1 ...... treatment-experienced patients
@en
P2093
Alexander Thielen
Conan K Woods
Douglass Chapman
Hernan Valdez
Jayvant Heera
Luke C Swenson
Marilyn Lewis
Mark A Jensen
P Richard Harrigan
P2860
P304
P356
10.1093/INFDIS/JIQ030
P407
P577
2011-01-01T00:00:00Z